AVA Genomics Consultancy ApS: Financial statements 2021
CVR: 37493678
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
AVA Genomics Consultancy ApS (CVR 37493678) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 33,746 and a net result of DKK 25,322 compared with DKK -135 the year before. Equity in the 2021 report amounted to DKK 35,161. The solvency ratio was 63.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 33,746
- Profit/Loss
- DKK 25,322
- Equity
- DKK 35,161
- Total Assets
- DKK 55,684
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 34 t. | 25 t. | 35 t. | 1 |
| 2020 | - | -117 | -135 | 10 t. | 0 |
| 2019 | - | 18 t. | 10 t. | 10 t. | 0 |
| 2018 | - | -2 t. | -2 t. | -114 | 0 |
Official annual report
Find more companies like AVA Genomics Consultancy ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
On October 11, 2021, the company changed its name from AVA Genomics and Breeding Consultancy IVS to AVA Genomics Consultancy ApS.
About AVA Genomics Consultancy ApS
AVA Genomics Consultancy ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AVA Genomics and Breeding Consultancy IVS. The management consists of Haja Najeemudin Kadarmideen. The company is owned by Haja Najeemudin Kadarmideen. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 14,728 and a net result of DKK -4,294 compared with DKK -18,733 the year before. Equity in the 2026 report amounted to DKK 90,595.